Want to join the conversation?
$BMY expects 2016 GAAP and non-GAAP EPS of $2.30-2.40, which assumes current exchange rates. Worldwide revenues are expected to increase in the mid-single digit range. The company also expects 2016 research and development expenses to increase in the high-single digit range.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?